1. Host-defense peptides of Australian anurans. Part 2. Structure, activity, mechanism of action, and evolutionary significance.
- Author
-
Bowie JH, Separovic F, and Tyler MJ
- Subjects
- Amino Acid Sequence, Amphibian Proteins genetics, Amphibian Proteins pharmacology, Animals, Anti-Infective Agents pharmacology, Antimicrobial Cationic Peptides genetics, Antimicrobial Cationic Peptides pharmacology, Australia, Evolution, Molecular, Humans, Molecular Sequence Data, Muscle Contraction drug effects, Neuropeptides chemistry, Neuropeptides genetics, Neuropeptides pharmacology, Nitric Oxide Synthase Type I antagonists & inhibitors, Oligopeptides genetics, Oligopeptides pharmacology, Pheromones chemistry, Pheromones genetics, Protein Structure, Secondary, Amphibian Proteins chemistry, Anti-Infective Agents chemistry, Antimicrobial Cationic Peptides chemistry, Anura genetics, Oligopeptides chemistry
- Abstract
A previous review summarized research prior to 2004 carried out on the bioactive host-defense peptides contained in the skin secretions of Australian anurans (frogs and toads). This review covers the extension of that research from 2004 to 2012, and includes membrane-active peptides (including antibacterial, anticancer, antifungal and antiviral peptides) together with the mechanisms by which these peptides interact with model membranes, peptides that may be classified as "neuropeptides" (including smooth muscle active peptides, opioids and immunomodulators) and peptides which inhibit the formation of nitric oxide from neuronal nitric oxide synthase. The review discusses the outcome of cDNA sequencing of signal-spacer-active peptides from an evolutionary viewpoint, and also lists those peptides for which activities have not been found to this time., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF